A new study suggests the ketogenic diet is more effective than a low-fat diet for type 2 diabetes remission, specifically by improving beta-cell function and reducing proinsulin secretion.
This research is significant because it highlights how carbohydrate restriction might alleviate stress on beta-cells, potentially restoring their function and offering a new therapeutic avenue for diabetes management.
Future research is crucial to fully understand the long-term mechanisms and sustainability of the ketogenic diet's impact on beta-cell repair and overall glycemic control in type 2 diabetes patients.

Atlas AI
A recent study indicates that a ketogenic diet may be more effective than a low-fat diet in achieving remission for individuals with type 2 diabetes. The research focused on beta-cell function, a key indicator of pancreatic health in diabetic patients.
Participants following a ketogenic diet demonstrated a greater reduction in the proportion of proinsulin secreted. This change is associated with improved beta-cell function, suggesting a potential for better glycemic control.
Both ketogenic and low-fat diet groups experienced weight loss. However, the ketogenic diet specifically reduced the stress on beta-cells, allowing them to operate more efficiently.
This finding suggests that carbohydrate restriction may create an environment conducive to the repair of beta-cell secretory mechanisms. Further research is needed to identify the specific mechanisms behind this effect and to assess long-term adherence and outcomes.


